Neuronetics (STU:NRC) Beginning Cash Position : €29.06 Mil (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Neuronetics Beginning Cash Position?

Neuronetics's Beginning Cash Position for the quarter that ended in Dec. 2024 was €29.06 Mil.

Neuronetics's quarterly Beginning Cash Position declined from Jun. 2024 (€44.34 Mil) to Sep. 2024 (€23.67 Mil) but then increased from Sep. 2024 (€23.67 Mil) to Dec. 2024 (€29.06 Mil).

Neuronetics's annual Beginning Cash Position declined from Dec. 2022 (€88.87 Mil) to Dec. 2023 (€64.50 Mil) and declined from Dec. 2023 (€64.50 Mil) to Dec. 2024 (€56.99 Mil).

Neuronetics Beginning Cash Position Historical Data

The historical data trend for Neuronetics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuronetics Beginning Cash Position Chart

Neuronetics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Beginning Cash Position

Get a 7-Day Free Trial

62.23

43.33

88.87

64.50

56.99

Neuronetics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Beginning Cash Position	Get a 7-Day Free Trial															32.87	54.90	44.34	23.67	29.06

Neuronetics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Neuronetics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Neuronetics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Neuronetics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Neuronetics Inc (STU:NRC) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

STIM:USA NRC:Germany

Address

3222 Phoenixville Pike, Malvern, PA, USA, 19355

Website

https://www.neurostar.com

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.